← Eichor
Study identifier: NCT06965374 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Condition: Parkinson Disease  ·  Sponsor: AbbVie

PhaseN/A
Planned participants270
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective Foslevodopa/Foscarbidopa is in treating Italian adult participants with advanced Parkinson disease under routine clinical practice. This study will also assess the caregiver quality of life (QOL) (if caregiver is present). Foslevodopa/Foscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 270 adult participants who are prescribed Foslevodopa/Foscarbidopa by their doctors will be enrolled across approximately 19 sites in Italy. Participants will receive Foslevodopa/Foscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 12 months. There is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.

This description comes directly from the study's public registry record.

Talk to the study team

Caterina Golotta  ·  +39 06 548891  ·  caterina.golotta@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (19)

IRCCS Oasi SS. Troina /ID# 273507Troina, Enna, ItalyRecruiting
Istituto Neurologico Mediterraneo Neuromed S.P.A. - Irccs /Id# 272695Pozzilli, Isernia, ItalyRecruiting
ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO /ID# 272949Milan, Milano, ItalyRecruiting
Fondazione IRCCS Istituto Neurologico Carlo Besta /ID# 273225Milan, Milano, ItalyRecruiting
Azienda Ospedaliera Universitaria Luigi Vanvitelli /ID# 273434Naples, Napoli, ItalyRecruiting
A.O.U. CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO - Ospedale Molinette /ID# 273276Turin, Piedmont, ItalyRecruiting
Azienda Ospedaliera Universitaria Policlinico Tor Vergata /ID# 272834Rome, Roma, ItalyRecruiting
Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 273562Rome, Roma, ItalyRecruiting
Fondazione Policlinico Universitario Agostino Gemelli IRCCS-Universita Cattolica /ID# 274539Rome, Roma, ItalyRecruiting
Azienda Ulss 3 Serenissima /ID# 273027Venice, Venezia, ItalyRecruiting
Azienda Ospedaliero Universitaria delle Marche /ID# 272694Ancona, ItalyRecruiting
Ospedale Bellaria - Azienda Usl Di Bologna /ID# 274463Bologna, ItalyRecruiting

+ 7 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06965374